3rd April 2023

Pharmanovia received SBTi approval for Net Zero Emissions Targets

Basildon, UK, 3rd April 2023 Pharmanovia, a global pharmaceutical company that revitalises, extends and expands the...

More information
29th March 2023

Pharmanovia expands exclusive licensing collaboration with Aquestive Therapeutics

For Trade, Business and Medical Media only Basildon, UK – For immediate release, 27 March 2023...

More information
22nd March 2023

Pharmanovia enters into exclusive licensing agreement with Aeterna Zentaris

FOR TRADE AND BUSINESS MEDIA ONLY

More information

For all media enquiries please contact: communications@pharmanovia.com